« Back
Home /
Aganepag isopropyl

Aganepag isopropyl

Item no.	HY-19923-1ea
Manufacturer	MedChem Express
CASRN	910562-20-8
Amount	1 ea
Quantity options	10 mM/1 mL 10 mg 1 ea 1 mg 25 mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Molecules
Specific against	other
Purity	98.23
Citations	[1] Impagnatiello F, et al. Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma. Br J Pharmacol. 2019;176(8):1079-1089.\|[2]Matsou A, et al. Investigational drugs targeting prostaglandin receptors for the treatment of glaucoma. Expert Opin Investig Drugs. 2018;27(10):777-785.
Smiles	O=C(C1=CC=C(CCC[C@@H](CC2)N(C3=CC=C([C@@H](O)CCCCC)C=C3)C2=O)S1)OC(C)C
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	AGN-210961
Shipping Condition	Room temperature
Available
Manufacturer - Type	Reference compound
Manufacturer - Applications	Metabolism-protein/nucleotide metabolism
Manufacturer - Targets	Prostaglandin Receptor
Shipping Temperature	Room Temperature
Storage Conditions	-20°C, 3 years; 4°C, 2 years (Powder)
Molecular Weight	471.65
Product Description	Aganepag isopropyl (AGN-210961) is an EP2 agonist[1][2].
Manufacturer - Research Area	Endocrinology
Solubility	DMSO: ≥ 200 mg/mL
Manufacturer - Pathway	GPCR/G Protein
Isoform	EP
Clinical information	Phase 2

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-19923-1ea-safety-datasheet.pdf